Biological E to get Rs 1,500-crore advance for 30-crore doses
Biological E’s vaccine – a RBD protein sub-unit vaccine – is currently undergoing Phase-3 clinical trials after showing promising results in phases 1 and 2. The government will make an advance payment of Rs 1,500 crore to Biological E for reserving 300 million vaccine doses. These vaccine doses will be manufactured and stockpiled by Biological … Read more